0001362118-23-000033.txt : 20230524 0001362118-23-000033.hdr.sgml : 20230524 20230524091655 ACCESSION NUMBER: 0001362118-23-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230522 FILED AS OF DATE: 20230524 DATE AS OF CHANGE: 20230524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreiber Justin CENTRAL INDEX KEY: 0001720512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 23950783 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-05-22 0 0000948320 LifeMD, Inc. LFMD 0001720512 Schreiber Justin 236 FIFTH AVENUE SUITE 400 NEW YORK NY 10001 0 1 0 0 CEO 0 Common Stock, par value $0.01 2023-05-22 4 P 0 17664 2.152 A 2812284 D Common Stock, par value $0.01 2023-05-23 4 P 0 32336 2.06 A 2844620 D The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.13 to $2.16 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Includes 2,794,620 shares previously reported as held indirectly which were distributed to the Reporting Person and are now held directly. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.995 to $2.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Justin Schreiber 2023-05-24